Skip to content
HeyJared

Michal Ruprecht

Reporter · US

Indexed articles, last 90 days
1
Latest publication
Aug 13, 2026
Outlet visibility, for Jefferson Public Radio
Top 5M sites
Earliest in this view
Aug 13, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 13, 2026 · Michal Ruprecht

    The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews (opens the original)

    Excerpt · English

    Read excerpt

    Kalisizo, Uganda — Along the deeply rutted red dirt roads of central Uganda's Lake Victoria coast, there is little for miles beyond banana groves and bustling markets. The landscape is unassuming — and very dusty. Yet few places have done more to shape HIV care. Irene knows this well. For the past three years, the soft-spoken 22-year-old, who is HIV-negative, has been a participant in one of the most influential HIV clinical trials. She asked NPR to only use her first name for fear of discrimina

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For Jefferson Public Radio, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Michal Ruprecht